XyloCor Therapeutics
Malvern, PA
XyloCor Therapeutics is a development-stage, biotechnology company dedicated to developing first-in-class gene therapies for patients with unmet medical need in cardiovascular disease.
xylocor.comCompany Details
Founded
- 2013
Employees
- Between 10 - 50 employees
Raised
- $107,100,000
Headquarters Location
- Malvern, PA
Public
- No
Acquired
- No
CEO
Albert Gianchetti
Founders
- Todd RosengartRonald Crystal
Company Collections
These are collections XyloCor Therapeutics is a part of. Click on the collection name to view similar companies.